Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. [electronic resource]
Producer: 20200109Description: 319-347 p. digitalISSN:- 1878-7479
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.